|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.18 HKD | -1.27% |
|
+4.60% | -3.44% |
| 06-10 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
| 06-09 | Zai Lab Says China Approves Tivdak for Cervical Cancer Treatment | MT |
| Market Cap | 1.92B 15.03B 1.65B 1.52B 1.43B 2.68B 182B 2.71B 18.02B 7B 88.69B 7.2B 7.04B 307B | P/E Ratio 2026 * |
-7.71x | P/E Ratio 2027 * | -9.15x |
|---|---|---|---|---|---|
| Enterprise Value | 1.47B 11.55B 1.27B 1.17B 1.1B 2.06B 140B 2.08B 13.85B 5.39B 68.2B 5.53B 5.42B 236B | EV / Sales 2026 * |
3.29x | EV / Sales 2027 * | 2.57x |
| Free-Float |
95.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zai Lab Limited
| 1 day | -1.27% | ||
| 1 week | +4.60% | ||
| Current month | -5.25% | ||
| 1 month | -12.60% | ||
| 3 months | -7.83% | ||
| 6 months | -7.83% | ||
| Current year | -3.44% |
| 1 week | 12.49 |  | 13.84 |
| 1 month | 12.49 | | 16.16 |
| Current year | 12.31 | | 20.42 |
| 1 year | 12.31 | | 33.6 |
| 3 years | 10.56 | | 35.5 |
| 5 years | 10.56 | | 142 |
| 10 years | 10.56 | | 151.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Du
CEO | Chief Executive Officer | 60 | 01/04/2014 |
Ya jing Chen
DFI | Director of Finance/CFO | 58 | 07/07/2023 |
Rafael Amado
PSD | President | 62 | 01/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Du
CHM | Chairman | 60 | 01/04/2014 |
John Diekman
BRD | Director/Board Member | 82 | 01/01/2017 |
Peter Wirth
BRD | Director/Board Member | 74 | 01/01/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.27% | +4.60% | - | - | 1.92B | |
| +0.11% | -3.67% | +15.66% | -20.23% | 62.28B | |
| +1.44% | +5.33% | +68.19% | +222.27% | 60.59B | |
| +0.70% | +29.50% | +29.50% | +29.50% | 39.55B | |
| +0.26% | +9.80% | -54.99% | -65.15% | 36.8B | |
| +0.05% | +2.41% | +53.12% | -34.32% | 29.53B | |
| +0.65% | +6.01% | +60.19% | +75.19% | 21.68B | |
| +0.54% | +5.21% | +87.14% | -61.00% | 19.8B | |
| +4.80% | -0.20% | -5.27% | +115.05% | 16.96B | |
| +0.18% | -1.66% | +54.11% | +100.91% | 16.16B | |
| Average | +0.75% | +3.10% | +34.18% | +40.25% | 33.71B | |
| Weighted average by Cap. | +0.78% | +2.99% | +31.76% | +46.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 449M 3.52B 387M 356M 334M 626M 42.67B 634M 4.22B 1.64B 20.75B 1.68B 1.65B 71.75B | 596M 4.67B 513M 473M 443M 832M 56.64B 842M 5.59B 2.18B 27.54B 2.23B 2.19B 95.24B |
| Net income | -241M -1.89B -208M -191M -179M -336M -22.91B -340M -2.26B -880M -11.14B -904M -885M -38.52B | -156M -1.23B -135M -124M -116M -218M -14.88B -221M -1.47B -571M -7.24B -587M -575M -25.02B |
| Net Debt | -443M -3.47B -382M -352M -330M -619M -42.14B -626M -4.16B -1.62B -20.49B -1.66B -1.63B -70.86B | -387M -3.03B -334M -307M -288M -541M -36.82B -547M -3.64B -1.41B -17.91B -1.45B -1.42B -61.91B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 13.18 $ | -1.27% | 26,955,160 |
| 11/06/26 | 13.35 $ | +0.68% | 13,100,700 |
| 10/06/26 | 13.26 $ | +5.57% | 15,775,900 |
| 09/06/26 | 12.56 $ | -3.01% | 12,143,400 |
| 08/06/26 | 12.95 $ | +2.78% | 12,941,095 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZLAB Stock
- 9688 Stock
Select your edition
All financial news and data tailored to specific country editions
